The Future of Medicine Is Now

Posted on January 2nd, 2013 by Logan Lafferty

In our era of instant gratification, the world of medicine seems like an outlier. The path from a promising discovery to an effective treatment often takes a decade or more…After years of controversy, gene therapy is poised to become a viable option for a variety of often life-threatening medical conditions, especially those resulting from a single defective gene. Last month, the European Union approved Glybera for treatment of a rare genetic disease, making it the first gene-therapy medicine approved in the Western world. The approval comes amid a flurry of research showing broader promise for the approach in a range of disorders, from a rare form of blindness to hemophilia to heart failure. Though outright cures are still elusive, gene therapy "is beginning to emerge as a meaningful clinical" strategy, says Stephen J. Russell, director of molecular medicine at the Mayo Clinic in Rochester, Minn.

Wall Street Journal

Tags: blindness, defective gene, gene therapy, Genomics, Glybera, heart failure, hemophelia, Mayo Clinic Rochester, molecular medicine, Research, Stephen J. Russell, Wall Street Journal

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy